Subscribe To
Panbela: biotech with updated patent protection and unmet market target indication
Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the America...
January 5, 2022, 9:27 pm
Panbela: biotech with updated patent protection and unmet market target indication
Data from phase 1b study using SBP-101 for patients with pancreatic cancer will be shown at the America...
January 5, 2022, 9:27 pm
Ensysce biosciences: developing new class of tamper-proof powerful opioids
Ensysce Biosciences is using its proprietary Trypsin-Activated Abuse Protection and Multi-Pill Abuse Resistance to develop tamper-proof, powerful opio...
December 17, 2021, 11:04 pm
Ensysce biosciences: developing new class of tamper-proof powerful opioids
Ensysce Biosciences is using its proprietary Trypsin-Activated Abuse Protection and Multi-Pill Abuse Resistance to develop tamper-proof, powerful opio...
December 17, 2021, 11:04 pm
Ensysce biosciences: developing new class of tamper-proof powerful opioids
Ensysce Biosciences is using its proprietary Trypsin-Activated Abuse Protection and Multi-Pill Abuse Resistance to develop tamper-proof, powerful opio...
December 17, 2021, 11:04 pm
Cineplex wins lawsuit against cineworld in scrapped acquisition deal; damages of nearly $1b awarded
UPDATED: Cineplex today announced that it had prevailed in its lawsuit against Cineworld Group. The case centered on a deal in which Cineworld was to ...
December 14, 2021, 9:17 pm
Cineplex wins lawsuit against cineworld in scrapped acquisition deal; damages of nearly $1b awarded
UPDATED: Cineplex today announced that it had prevailed in its lawsuit against Cineworld Group. The case centered on a deal in which Cineworld was to ...
December 14, 2021, 9:17 pm
Cineplex wins lawsuit against cineworld in scrapped acquisition deal; damages of nearly $1b awarded
UPDATED: Cineplex today announced that it had prevailed in its lawsuit against Cineworld Group. The case centered on a deal in which Cineworld was to ...
December 14, 2021, 9:17 pm
Mongodb: a great buy in an uncertain market
One of the few tech companies that has remained rather stable throughout the uncertainty of 2021 is MongoDB with a return of 51.70% YTD. MongoDB is a ...
December 12, 2021, 5:59 pm
Mongodb: a great buy in an uncertain market
One of the few tech companies that has remained rather stable throughout the uncertainty of 2021 is MongoDB with a return of 51.70% YTD. MongoDB is a ...
December 12, 2021, 5:59 pm
Mongodb: a great buy in an uncertain market
One of the few tech companies that has remained rather stable throughout the uncertainty of 2021 is MongoDB with a return of 51.70% YTD. MongoDB is a ...
December 12, 2021, 5:59 pm
Frequency therapeutics' hearing loss candidate shows improved speech perception in noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P...
December 9, 2021, 1:18 pm
Frequency therapeutics' hearing loss candidate shows improved speech perception in noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P...
December 9, 2021, 1:18 pm
Frequency therapeutics' hearing loss candidate shows improved speech perception in noise
Frequency Therapeutics Inc (NASDAQ: FREQ) shared the results from its FX-322-113 study of FX-322 in severe sensorineural hearing loss (SNHL). The P...
December 9, 2021, 1:18 pm
Smith & wesson: no drivers ahead
Amid the social crisis of 2020 in the United States, the demand for firearms has grown. The company's revenue in fiscal 2021 increased by 100% and exc...
December 9, 2021, 1:06 pm
Smith & wesson: no drivers ahead
Amid the social crisis of 2020 in the United States, the demand for firearms has grown. The company's revenue in fiscal 2021 increased by 100% and exc...
December 9, 2021, 1:06 pm
Smith & wesson: no drivers ahead
Amid the social crisis of 2020 in the United States, the demand for firearms has grown. The company's revenue in fiscal 2021 increased by 100% and exc...
December 9, 2021, 1:06 pm
Elon musk sells another $1.01b worth of tesla stock to pay his tax bill
Tesla Inc (NASDAQ: CEO) Elon Musk has sold another 934,091 shares worth nearly $1.01 billion in order to fulfill his tax obligations, as per filings m...
December 2, 2021, 11:42 pm
Elon musk sells another $1.01b worth of tesla stock to pay his tax bill
Tesla Inc (NASDAQ: CEO) Elon Musk has sold another 934,091 shares worth nearly $1.01 billion in order to fulfill his tax obligations, as per filings m...
December 2, 2021, 11:42 pm
Elon musk sells another $1.01b worth of tesla stock to pay his tax bill
Tesla Inc (NASDAQ: CEO) Elon Musk has sold another 934,091 shares worth nearly $1.01 billion in order to fulfill his tax obligations, as per filings m...
December 2, 2021, 11:42 pm